0001104659-24-010827.txt : 20240205
0001104659-24-010827.hdr.sgml : 20240205
20240205212432
ACCESSION NUMBER: 0001104659-24-010827
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240202
FILED AS OF DATE: 20240205
DATE AS OF CHANGE: 20240205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ashar Bhavesh
CENTRAL INDEX KEY: 0001849740
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39044
FILM NUMBER: 24597848
MAIL ADDRESS:
STREET 1: C/O SPRINGWORKS THERAPEUTICS
STREET 2: 100 WASHINGTON BLVD
CITY: STAMFORD
STATE: CT
ZIP: 05902
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SpringWorks Therapeutics, Inc.
CENTRAL INDEX KEY: 0001773427
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 WASHINGTON BOULEVARD
CITY: STAMFORD
STATE: CT
ZIP: 06902
BUSINESS PHONE: 203-883-9490
MAIL ADDRESS:
STREET 1: 100 WASHINGTON BOULEVARD
CITY: STAMFORD
STATE: CT
ZIP: 06902
4
1
tm245274-2_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-02-02
0
0001773427
SpringWorks Therapeutics, Inc.
SWTX
0001849740
Ashar Bhavesh
C/O SPRINGWORKS THERAPEUTICS, INC.
100 WASHINGTON BLVD.
STAMFORD
CT
06902
0
1
0
0
Chief Commercial Officer
0
Common Stock
2024-02-02
4
S
0
1089
43.7465
D
65121
D
Common Stock
2024-02-02
4
S
0
1667
44.3119
D
63454
D
Common Stock
2024-02-02
4
S
0
378
45.9979
D
63076
D
Common Stock
2024-02-02
4
S
0
88
46.3733
D
62988
D
Common Stock
2024-02-05
4
S
0
4834
49.3245
D
58154
D
The sales reported on this Form 4 were effected pursuant to a trading plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, adopted on December 16, 2022.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.05 to $44.035. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.05 to $44.77. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.29 to $46.28. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.29 to $47.11. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.00 to $49.71. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
/s/ Francis I. Perier, Jr. as Attorney-in Fact
2024-02-05